S
Synapse Medicine
Biotech & Life Sciences · Bordeaux, France · Founded 2017
Artificial intelligence platform to manage drugs prescription MoreLess
Synapse Medicine is a health technology company that provides AI-powered solutions to optimize drug regimens and enhance patient safety. The company serves healthcare providers and their patients, operating in the digital health market. Synapse Medicine's core product is a suite of pre-built, plug-and-play prescription assistance APIs and components that improve prescribing accuracy and safety. The business model is B2B (business-to-business), where healthcare organizations integrate Synapse Medicine's solutions into their platforms to streamline medication management and ensure safer patient care. Revenue is generated through subscription fees and licensing of their APIs and components. Synapse Medicine's innovative solutions, such as Synapse Copilot and Synapse Medication Shield, facilitate the management of adverse event reports and provide healthcare professionals with intelligent tools for better decision-making.
Keywords: AI-powered, drug regimens, patient safety, prescription assistance, healthcare providers, digital health, B2B, APIs, medication management, pharmacovigilance.
Company overview
Synapse Medicine company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- Bordeaux, France
- Employees
- 85
- Open positions
- 4
- Dealroom signal
- 73.6
Valuation & funding
Synapse Medicine funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Mar 2022 | $28M | $112M | XAnge · BNP Paribas Développement · MACSF · Korelya Capital | ↗ |
| SERIES A✓Equity / VC | Jul 2020 | $8M | $32M | Bpifrance · BNP Paribas · MACSF · XAnge | ↗ |
| SEED✓Equity / VC | Mar 2019 | $2.8M | $11M | XAnge | — |
| SPINOUT✓Other financing | Jan 2017 | — | — | University of Bordeaux · INSERM · University Hospital of Bordeaux | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | Profit | Margin |
|---|---|---|---|---|
| 2026 | $77K | 0% | −$1.1M | -1469.6% |
| 2025 | $77K | 0% | −$1.1M | -1469.6% |
| 2024 | $77K | 0% | −$1.1M | -1469.6% |
| 2023 | $77K | 0% | ||
| 2022 | $77K | 0% | ||
| 2021 | $77K | 0% | ||
| 2020 | $77K | — |
Growth signals
Synapse Medicine website traffic
Latest recorded traffic for Synapse Medicine is 27K monthly website visits, up 28.6% over the last three months. Synapse Medicine's team grew 1.2% over the past year.
Hiring
Open positions at Synapse Medicine
Current openings linked to this company in Dealroom.
Comparisons
Synapse Medicine compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 GleamerProviding imaging users a suite of Artificial Intelligence solutions covering a wide range of clinical applications |
Saint-Mandé, France | Acquired | 124 | $45M | $119M |
 inHEARTAI-enabled digital twin of the heart |
Pessac, France | Operational | |||
 TherapixelSoftware company specialized in artificial intelligence for medical image analytics |
Paris, France | Operational | |||
 Keen EyeAnalyzes and reviews slide images |
Paris, France | Closed | |||
 PixylNeuroimaging AI for Improved Patient Care |
La Tronche, France | Acquired | |||
 THERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care |
Paris, France | Operational | |||
 SurgeInnovative fingerprinting of the immune system with AI to holistically improve the perioperative standard-of-care |
Paris, France | Operational | |||
 SonioAn AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations |
Paris, France | Acquired |
Talent graph
Synapse Medicine's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Synapse Medicine has talent and traffic
team presence
In the news
Latest news about Synapse Medicine
Recent press, funding announcements, and product moves mentioning Synapse Medicine — open to read from the original sources.
Market sentiment
What the market is saying about Synapse Medicine
An AI-synthesized read of the highest-engagement posts about Synapse Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Synapse Medicine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.